By:
Nuki
OpenAI has announced GPT-4B Micro, its first biological AI model, which focuses on advancing regenerative medicine and anti-aging research. Trained on diverse protein sequences, this model optimizes cellular reprogramming, significantly improving the efficiency of turning adult cells into stem cells using Yamanaka factors—by a factor of 50. This breakthrough could revolutionize medical treatments, including organ replacement and disease therapies. Sam Altman, OpenAI’s CEO, supports this…
